Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
5,245 USD | +0,33% |
|
-15,78% | -23,32% |
Métier
Nombre d'employés: 9
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Robert Bitterman
CEO | Chief Executive Officer | 73 | 19/06/12 |
Caitlin Kontulis
DFI | Director of Finance/CFO | - | - |
James Cardia
CTO | Chief Tech/Sci/R&D Officer | - | 15/09/17 |
Linda M. Mahoney
PRN | Corporate Officer/Principal | - | 10/11/22 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Robert Bitterman
CEO | Chief Executive Officer | 73 | 19/06/12 |
Director/Board Member | 73 | 02/05/22 | |
Curtis Lockshin
BRD | Director/Board Member | 64 | 18/04/13 |
Jonathan Freeman
BRD | Director/Board Member | 56 | 07/06/17 |
Robert Ferrara
BRD | Director/Board Member | 73 | 01/10/19 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 510 189 | 507 177 ( 99,41 %) | 0 | 99,41 % |
Coordonnées société
Phio Pharmaceuticals Corp.
11 Apex Drive Suite 300A PMB 2006
01752, Marlborough
+508-767-3861
http://www.phiopharma.com![Adresse Phio Pharmaceuticals Corp.(PHIO)](https://cdn.zonebourse.com/static/address/47281669.png)
Secteur
![Consensus](/images/consensus_flch.gif)
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
-23,32% | 2,68 M | |
+18,97% | 45,34 Md | |
+41,98% | 40,42 Md | |
-10,06% | 37,92 Md | |
+31,15% | 31,75 Md | |
-7,79% | 27,71 Md | |
+13,32% | 26,52 Md | |
+43,05% | 13,96 Md | |
+31,28% | 12,44 Md | |
-7,41% | 11,26 Md |
- Bourse
- Actions
- Action PHIO
- Société Phio Pharmaceuticals Corp.